Ameriprise’s Fennec Pharmaceuticals FENC Stock Holding History

Ameriprise’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,090	Closed	-$86K	–	3781
2020 Q3	$86K	Buy	+14,090	New	+$99.3K	﹤0.01%	3653

Other funds holding FENC

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Ameriprise's FENC Position: Q4 2020 in Review

Ameriprise sold out of Fennec Pharmaceuticals (FENC) in Q4 2020, closing a stake of 14,090 shares — an estimated $86K sold.

Ameriprise first reported a position in FENC in Q3 2020 and held it in 1 quarter. The position peaked at $86K in Q3 2020. 52 funds tracked by Wall St. Rank hold FENC as of Q4 2020.

Ameriprise reported no remaining Fennec Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Ameriprise sold 14,090 Fennec Pharmaceuticals shares in Q4 2020, an estimated $86K.
Ameriprise first reported a position in Fennec Pharmaceuticals in Q3 2020 and held it in 1 quarter.
Ameriprise's Fennec Pharmaceuticals position peaked at $86K in Q3 2020.
52 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2020.

Based on Ameriprise's 13F filing for Q4 2020, filed 12 Feb 2021.